In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify cannabis as being a Program III drug. This rescheduling will acknowledge that cannabis has legitimate health care needs and can help open the doorway to investigation on other possible treatment method takes advantage of.The internet site is protected. The htt